Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02203032 |
|---|---|
| Brief Title: | A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab (NAVIGATE) |
| First Submitted : | July 25, 2014 |
| First Submitted that Met QC Criteria : | July 25, 2014 |
| First Posted : | July 29, 2014 (Estimate) |
| Results First Submitted : | June 14, 2017 |
| Results First Submitted that Met QC Criteria : | June 14, 2017 |
| Results First Posted : | July 17, 2017 |
| Certification/Extension First Submitted : | July 12, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | July 12, 2016 |
| Certification/Extension First Posted : | July 14, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 11, 2017 |
| Last Update Posted : | September 12, 2017 |